Coronavirus Global Updates, Feb 21 ::::Global Vaccines Reach 202 Million , Philippines Confirms 18 Additional Cases of U.K. Variant and Russia Reports Lowest New Cases Since Oct. 9

[Bulls n Bears]

 <https://bullszimbabwe.com/> 

 


 

 <http://www.bullszimbabwe.com> Bullszimbabwe.com
<mailto:info at bulls.co.zw?subject=View%20and%20Comments> Views & Comments
<https://bullszimbabwe.com/category/blogs/bullish-thoughts/> Bullish
Thoughts        <http://www.twitter.com/BullsBears2010> Twitter
<https://www.facebook.com/BullsBearsZimbabwe> Facebook
<http://www.linkedin.com/pub/bulls-n-bears-zimbabwe/57/577/72> LinkedIn
<https://chat.whatsapp.com/CF6wllAfScU9Wr6dXxoQnO> WhatsApp
<mailto:info at bulls.co.zw?subject=Unsubscribe> Unsubscribe

 


 

 


Coronavirus Global Updates, Feb 21 ::::Global Vaccines Reach 202 Million ,
Philippines Confirms 18 Additional Cases of U.K. Variant  and Russia Reports
Lowest New Cases Since Oct. 9

 


 

 


 <https://www.nicozdiamond.co.zw/>  

 


 

 



Zimbabwe COVID19 Update


COVID-19 update: As at 20 February 2021, Zimbabwe had 35 768 confirmed
cases, including 32 096 recoveries and 1 432 deaths.

 



Global Vaccines Top 202 Million; Russia Cases Slow: Virus Update
Serbia added a fourth vaccine to its program by taking delivery from
AstraZeneca Plc while Australia kicked off its program on Sunday and South
Korea will start rolling out vaccinations from Friday. The U.K. will offer
doses to
<https://www.bloomberg.com/news/articles/2021-02-20/u-k-speeds-vaccine-progr
am-to-offer-all-adults-shot-by-july-31> all adults by the end of July as the
government beefs up efforts to contain one of the world’s worst outbreaks.


Russia reported its lowest new cases since October while Johnson & Johnson’s
Covid-19 vaccine is expected to be given European Union approval in the next
two to four weeks. Fujifilm Holdings Corp. plans to restart clinical trials
of Avigan in April, Nikkei reported.


German Contagion Rate Rises to Highest in More Than a Week 
Germany’s seven-day Covid-19 incidence rate per 100,000 people inched up on
Sunday to the highest level in over a week -- the latest evidence that a
steady decline since a peak before Christmas has ground to a halt.


The rate rose to 60.2, the highest level since Feb. 12, according to data
from the RKI public-health institute. The increase comes as pressure grows
on the government to lay out a reopening plan, even amid concerns about
fast-spreading variants. The government has said a rate of 50 or below is
manageable and may allow a cautious easing of lockdown restrictions
including shuttered schools and non-essential stores.


Russia Reports Lowest New Cases Since Oct. 9 
Russia reported 12,742 new cases of Covid-19, the lowest since Oct. 9,
according to the government’s virus response center. Total cases have
reached 4.16 million.


The data show 417 people died in the past day, pushing the death toll to
83,293 since the start of the pandemic. Federal statistics show the number
of deaths linked to Covid-19 last year was nearly three times higher than
the government response center reported.


Serbia Adds Fourth Vaccine With AstraZeneca Delivery 
Serbia received its first delivery of AstraZeneca shots on Sunday, adding a
fourth vaccine to its program after already importing nearly 2 million doses
from Pfizer-BioNTech, China’s Sinopharm as well as the Russian Sputnik V.


Around 756,000 people in the Balkan nation of 7 million have been
vaccinated, including almost 500,000 with two doses, President Aleksandar
Vucic told reporters at Belgrade airport where the shipment was delivered.

Serbia donated 2,000 shots to Montenegro as its smaller neighbor kicked off
inoculations on Saturday. The Adriatic country’s population is around
650,000.


Iran Says Barakat Vaccine 90% Effective Against Coronavirus 
Iran’s homemade COVIran Barakat vaccine for Covid-19 is 90% effective
against the virus, the state-run Islamic Republic News Agency reported.


The vaccine is currently in its second stage of human trials and officials
plan to have over 20,000 people inoculated by the vaccine by May 20,
according to the semi-official Young Journalists Club.


Philippines Confirms 18 Additional Cases of U.K. Variant 
The Philippines confirmed 18 additional cases of the coronavirus variant
first found in the U.K., bringing the total of such cases to 62 as of
Sunday, according to the Department of Health. Thirteen of the cases are
returning overseas Filipino workers who entered the country between January
3-27, and all of these cases are now tagged as recovered, it said.


The country also detected N501Y and E484K mutations in three samples from
confirmed Covid-19 patients in its central Visayas islands, the Health
Department also said. “Investigation is now underway to aid in curbing
transmission,” it said in a statement.


Italian Governors to Push Central Government for More Vaccines 
Regional governors will request the Italian government increase efforts to
find more vaccine doses as they also seek new parameters for the tightening
restrictions in pars of the country.


The requests were outlined in a joint statement after the regional leaders
met to discuss ways to deal with the pandemic.


Switzerland May Resell its AstraZeneca Doses Amid Efficacy Concern, NZZ Says

Switzerland may resell its 5.3 million doses of AstraZeneca’s vaccine amid
questions over its efficacy, Neue Zürcher Zeitung reported Sunday.


There are considerations about passing the material on, said Nora Kronig,
the deputy director of the Federal Office of Public Health. The country’s
regulator, Swissmedic, has not yet approved the shot and is requesting more
data from a trial underway in North and South America.


South Korea to Use AstraZeneca Vaccine From Friday 
South Korea will commence its vaccinations on Friday using AstraZeneca’s
shot, Prime Minister Chung Sye-kyun said Sunday in a televised briefing.


Pfizer’s vaccine will be used to inoculate medical personnel from Saturday,
a day after enough supplies to treat 117,000 people are due to arrive in the
country, he said.


Malaysia to Start Covid-19 Vaccinations Ahead of Plan, Star Reports 
Malaysia will start its Covid-19 vaccination program on Feb. 24, two days
ahead of schedule, The Star reported, citing Science, Technology and
Innovation Minister Khairy Jamaluddin after the first batch of vaccines
arrived on Sunday.


Prime Minister Muhyiddin Yassin will be the first to receive the vaccine,
followed by Health Director-General Noor Hisham Abdullah, according to the
report. The first batch of 312,390 Pfizer-BioNTech vaccines will be
administered to over 271,000 frontline workers, of whom 57.3% are medical
personnel and 42.7% non-medical staff, it said.


Global Vaccines Reach 202 Million 
More than 202 million vaccine doses have been administered around the world,
according to data compiled by the Bloomberg Vaccine Tracker, just over two
months after the first shots went into arms.


Vaccinations are underway in at least 88 countries, including nations in
Africa, Asia, Europe and North and South America. While the doses given so
far are only a fraction of what will be needed to cover the globe, about
6.35 million doses a day are being administered.


Fujifilm Plans to Resume Avigan Trial in April, Nikkei Says 
Fujifilm Holdings Corp. plans to restart the clinical trials of Avigan in
April, the Nikkei newspaper reported without citing anyone.


Japanese regulators in December postponed a decision to approve the
company’s antiviral drug to treat Covid-19, asking the company for more
data. The decision to approve could come after October when the clinical
trials are seen to be completed, and upon review by the government, the
report said.


Australia Starts Vaccinations 
Australia’s vaccination program started on Sunday, with Prime Minister Scott
Morrison
<https://www.bloomberg.com/news/articles/2021-02-20/australia-starts-covid-v
accination-pm-among-first-to-get-a-shot> among the first to get an
injection.


Morrison and the nation’s chief medical and nursing officers will be among a
small group receiving the vaccination to help build public confidence in its
safety, Health Minister Greg Hunt said on ABC television. The broader
rollout will start on Monday.


Ex-Trump Official Says Grave ‘Mask Misstep’ Cost U.S. 
The Trump administration erred in not providing guidance on the
effectiveness of face masks early in the pandemic, said Matthew Pottinger,
former deputy national security adviser.


“The mask misstep cost us dearly. It was the one tool that was widely
available, at least homemade, you know, cotton masks were widely available,”
Pottinger said in an interview with CBS that will run in full on Sunday. “It
was the one effective, widely available tool that we had in the arsenal to
deal with this...It was a grave misstep.”

Surveys in 2020 showed that supporters of Donald Trump, and Republicans in
general, were less likely than Democrats to “mask up” to prevent the spread
of Covid-19.


U.K. to Offer All Adults Shots by July 
The U.K. will significantly accelerate its vaccination program, offering
shots to
<https://www.bloomberg.com/news/articles/2021-02-20/u-k-speeds-vaccine-progr
am-to-offer-all-adults-shot-by-july-31> all adults by the end of July and
everyone over 50 by mid-April as the government beefs up efforts to contain
one of the world’s worst outbreaks of the coronavirus.


Prime Minister Boris Johnson will set out the new targets on Monday when he
reveals his “roadmap” to easing lockdown restrictions. It is the first time
the government has given a firm target for when it expects to offer all
adults their initial dose, having previously said it hoped to do so by
autumn. The previous target set for over-50s was the end of May.




Pfizer Vaccine Prevents 99% of Deaths: Israel Ministry 
The vaccine developed by Pfizer Inc. and BioNTech SE is 98.9% effective at
preventing Covid-19 deaths, according to Israel’s Health Ministry.


Protection was highest two weeks after getting the second shot, while
effectiveness was at 94.5% a week after the second dose, according to data
the ministry released on Saturday.

The rates of preventing morbidity, symptomatic cases and hospitalization
were all higher than 95% two weeks past the second jab, the data show.


Second-Shot Crunch Leaves Many Without Full Immunizations 
Almost a month after U.S. vaccination campaigns ramped up to give Covid-19
shots to more than a million people a day, their second doses are coming
due,
<https://www.bloomberg.com/news/articles/2021-02-20/second-shot-crunch-leave
s-many-without-complete-immunizations> straining state rollouts and and
leaving some without complete immunizations.


In Texas alone, almost 6,000 people were overdue for their second shots in
early February. Washington state officials said earlier this week that some
mass vaccination clinics would only deliver follow-up doses. And a Michigan
hospital system canceled last-dose appointments for the past week after its
supply was reduced.

“For the first six weeks of this program or so, we were only giving first
shots, and now we have to kind of pay the piper,” said Eric Toner, a senior
scholar at the Johns Hopkins Center for Health Security.


Germany Expects J&J Vaccine Approval in 2-4 Weeks 
A rival shot developed by CureVac NV will take longer and may get the green
light in April or May, Spahn said during a virtual discussion on Germany’s
vaccination program.


Spahn added that Germany would have no problem using the Russian Sputnik V
vaccine as long as data and testing conformed with EU standards.


U.K. Care Home Restrictions Relaxed 
In news that will be welcomed by families who have been unable to see their
relatives in care homes for months, chosen visitors will be able to meet
indoors and hold hands, Health Secretary Matt Hancock confirmed in a
statement today.


Hancock said the proposed easing of strict care home measures is the “first
step to getting back to where we want to be.” Hancock’s statement comes
ahead of Prime Minister Boris Johnson revealing his “road map” for bringing
the nation out of lockdown on Monday.

 

 


 


 


 

 


 

INVESTORS DIARY 2021

 


Company

Event

Venue

Date & Time

 


 

 

 

 

 


 

 

 

 

 


Companies under Cautionary

 

 

 


 

 

 

 


ART

PPC

Dairibord

 


Starafrica

Fidelity

Turnall

 


Medtech

Zimre

Nampak Zimbabwe

 


 

 


DISCLAIMER: This report has been prepared by Bulls ‘n Bears, a division of
Faith Capital (Pvt) Ltd for general information purposes only and does not
constitute an offer to sell or the solicitation of an offer to buy or
subscribe for any securities. The information contained in this report has
been compiled from sources believed to be reliable, but no representation or
warranty is made or guarantee given as to its accuracy or completeness. All
opinions expressed and recommendations made are subject to change without
notice. Securities or financial instruments mentioned herein may not be
suitable for all investors. Securities of emerging and mid-size growth
companies typically involve a higher degree of risk and more volatility than
the securities of more established companies. Neither Faith Capital nor any
other member of Bulls ‘n Bears nor any other person, accepts any liability
whatsoever for any loss howsoever arising from any use of this report or its
contents or otherwise arising in connection therewith. Recipients of this
report shall be solely responsible for making their own independent
investigation into the business, financial condition and future prospects of
any companies referred to in this report. Other  Indices quoted herein are
for guideline purposes only and sourced from third parties.

 


 

 


(c) 2021 Web: <http://www.bullszimbabwe.com>  www.bullszimbabwe.com Email:
<mailto:info at bulls.co.zw> info at bulls.co.zw Tel: +263 4 2927658 Cell: +263 77
344 1674

 


 

 

 

 

 

 

 

 

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210221/95ec07c5/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 9458 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210221/95ec07c5/attachment-0003.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image006.png
Type: image/png
Size: 174 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210221/95ec07c5/attachment-0004.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.png
Type: image/png
Size: 224233 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210221/95ec07c5/attachment-0005.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image004.jpg
Type: image/jpeg
Size: 82482 bytes
Desc: not available
URL: <http://listmail.bulls.co.zw/pipermail/bulls/attachments/20210221/95ec07c5/attachment-0001.jpg>